Abstract

COVID -19: REVIEW ON AVAILABLE DRUGS AND THERAPIES AGAINST SARSCOV-2

Pushpa Yadav* and Imtiyaz Ahmad

ABSTRACT

COVID-19 is that the disease caused by an infection of the SARS-CoV-2 virus, first identified within the city of Wuhan, in China's Hubei province in December 2019. SARS-CoV-2 is the agent responsible for COVID-19. The Mild infection, the pulmonary phase and the inflammatory phase are the infection phases of covid-19. COVID-19 has a high rate of contagious and highly nonspecific symptoms. Covid-19 patients will experience mild to moderate symptoms such as respiratory symptoms, cough, dyspnoea, fever, and viral pneumonia and some recover without any special cure and some others need special and emergency treatment. Till now, there are numbers of proposed novel compounds as well as standards therapeutics agent existed for other conditions seems to have efficacy against the 2019-nCoV. There is no proven drug or vaccine for this yet. Aim of this paper is to review typical and ongoing drug treatments for corona virus disease.

Keywords: Covid-19, Drugs therapy, Chloroquine/Hydroxychloroquine, Remdesivir, Lopinavir/Ritonavir, Favipiravir, Corticosteroids.